Distinguished diabetes researcher Dr. Daniel Drucker elected to the Royal Society

One of Canada’s most celebrated researchers has been awarded yet another prestigious accolade, recognizing the powerful impact of his work on global diabetes knowledge and treatment. Dr. Daniel Drucker, Senior Investigator at Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute, was recently elected as a Fellow by the Royal Society – one of the U.K.’s most prominent scientific organizations.

Dr. Drucker, described as a giant in the field of diabetes research, is only the second individual worldwide to be recognized with all three major international diabetes awards. In 2014, Dr. Drucker received the world’s most valuable award for diabetes research, the Manpei Suzuki International Prize, as well as the prestigious Banting Medal for Scientific Achievement Award from the American Diabetes Association, sometimes described as the Nobel Prize for diabetes research. In 2011, he was awarded the Claude Bernard Medal from the European Association for the Study of Diabetes.

The Royal Society, which aims to support and celebrate scientific excellence to improve lives around the world, selects Fellows for life based on peer review. Dr. Drucker joins an eminent group of Fellows that includes around 80 Nobel Laureates. He was recognized for his pioneering studies of gut hormone action enabling development of three new classes of medications for treatment of diabetes and short bowel syndrome.

To learn more about how Dr. Drucker is contributing to diabetes care, click here.